Coumarins from campylotropis hirtella (Franch.) Schindl. and their inhibitory activity on prostate specific antigen secreted from LNCaP cells

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 9, 2008, Pages 1338-1341

  Han, Hui Ying ^a   Wen, Ping ^b   Liu, Hong Wei ^c   Wang, Nai Li ^d   Yao, Xin Sheng ^e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Traditional Chinese Medicine and Natural Medicine   (China)

^e JINAN UNIVERSITY   (China)

Author keywords

Benign prostate hyperplasia; Campylotropis hirtella; Coumarin; Prostate specific antigen

Indexed keywords

3,9 DIHYDROXYCOUMESTAN; 6 (2 ANGELOYLOXY 1,3 DIHYDROXY 3 METHYLBUTYL) 7 METHOXYCOUMARIN; 7,2',4' TRIHYDROXY 5 METHOXY 3 COUMARIN; 8 O METHYLMELLEIN; ALLOIMPERATORIN; ANGELOL A; ANGELOL B; ANGELOL G; ANGELOL M; BERGAPTEN; COLUMBIANETIN; COUMARIN DERIVATIVE; ISOPIMPINELLIN; LOMATIN ACETATE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; XATHOTOXIN;

ARTICLE; CAMPYLOTROPIS HIRTELLA; CELL ASSAY; CELL STRAIN LNCAP; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; HUMAN; HUMAN CELL; IC 50; LEGUME; PROSTATE HYPERTROPHY; PROTEIN SECRETION; TRADITIONAL MEDICINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COUMARINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FABACEAE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PLANT ROOTS; PROSTATE-SPECIFIC ANTIGEN; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 51349108393     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1338     Document Type: Article

References (19)

1. Lu X. Z., Xu W. B., Shen J. X., Zhongguo Zhongyao Zazhi, 22, 680-682 (1997).
2. Qin L., Chen X. M., Chen W. X., Yang L., Zhang C. K., Tianran Chanwu Yanjiu Yu Kaifa, 3, 31-34 (1991).
3. Roehrborn C. G., Boyle P., Bergner D., Gray T., Gittelman M., Shown T., Melman A., Bracken R. B., deVere White R., Taylor A., Wang D., Waldstreicher J., Urology, 54, 662-669 (1999a).
4. Roehrborn C. G., McConnell J. D., Lieber M., Kaplan S., Geller J., Malek G H., Castellanos R., Coffield S., Saltzman B., Resnick M., Cook T. J., Waldstreicher J., Urology, 53, 473-480 (1999b).
5. Han H. Y., Shan S., Zhang X., Wang N. L., Lu X. P., Yao X. S., Phytomedicine, 14, 338-343 (2007).
6. Hatano T., Aga Y., Shintani Y., Ito H., Okuda T., Yoshida T., Phytochemistry, 55, 959-963 (2000).
7. Hatano T., Yasuhara T., Miyamoto K., Okuda T., Chem. Pharm. Bull., 36, 2286-2288 (1988).
8. Baba K., Matsuyama Y., Koazwa M., Chem. Pharm. Bull., 30, 2025-2035 (1982).
9. Liu X H., Xu S. X., Yao X. S., Kobayashi H. Phytochemistry, 39, 1099-1101(1995).
10. Baba K., Matsuyama Y., Ishida T., Inoue M., Koazwa M., Chem. Pharm. Bull., 30, 2036-2044 (1982).
11. Kutney J. P., Verma A. K., Young R. N., Tetrahedron, 28, 5091-5104 (1972).
12. Liu Y. Y., Zhang C., Li L., Xiao Y. Q., China J. Chin. Mater. Med., 131, 309-311 (2006).
13. Ishi H., Hosoya K., Ishikawa T., Haginiwa J., Yakugaku Zasshi, 94, 309-321 (1974).
14. Matsuda H., Murakami T., Nishida N., Kageura T., Yoshikawa M., Chem. Pharm. Bull., 48, 1429-1435 (2000).
15. Xhomas S., Kula M. Regina., Müller Michael., Synthesis, 12, 2045-2048 (1999).
16. Liu Y., Ma X. X., Chen H. B., J. Chin. Pharm. Sci., 14, 75-78 (2005).
17. Rachel S. R. Z., David J. A. J., Xheodore J. B., Eleftherios P. D., Clin. Chim. Acta, 317, 17-26 (2002).
18. Davis J., Muqim N., Bhuiyan M., Kucuk P., Sarkar F., Int. J. Oncol., 16, 1091-1097 (2000).
19. Marshall M. E., Kervin K., Benefield C., Umerani A., Albainy-Jenei A., Zliao Q., Kliazaeli M. B., J. Cancer Res. Clin. Oncol., 120 (Suppl.), S3-S10 (1994).